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Case Presentation
A 30-year-old Puerto Rican man with a histo-
ry of asthma was referred for allergy skin test-
ing at his own request. The patient reported a
history of asthma since infancy. He had been
hospitalized twice for asthma exacerbations,
most recently 3 years earlier, and he had had
several asthma-related emergency room visits
in the past year. He reported ongoing symp-
toms of intermittent wheeze, dyspnea, pro-
ductive cough, and chest tightness. His sleep
was disturbed by these symptoms several
nights per week. His current medications were
a flunisolide metered-dose inhaler (MDI),
four inhalations twice daily, and an albuterol
MDI, two inhalations as needed, which he
had been requiring twice daily on most days
of the week.
The patient, who had a strong family
history of asthma, voiced his suspicion that
allergy to cockroaches might have some-
thing to do with his asthma. He reported
living in a severely cockroach-infested
apartment, a situation about which his
landlord was refusing to take any action. He
sometimes noticed red bumps on his skin
after getting out of bed in the morning, and
he wondered whether this might relate to
cockroaches, which he saw frequently in his
bedroom and throughout the apartment. In
the past, he had noticed itchy, watery eyes
after exposure to dogs or cats, but he denied
having pets or visiting homes with pets.
The patient had smoked cigarettes for the
past 14 years, and currently smokes seven
cigarettes per day.
Review of systems was notable for fre-
quent symptoms consistent with gastroe-
sophageal reflux. The patient was employed
in the housekeeping department at a local
university, where his job involved the mainte-
nance of classroom faciities. He denied expo-
sure to dust, fumes, or animals in his job.
On examination, the patient appeared
well. Vital signs were unremarkable, and the
skin was without rash. The nasal mucosa
was slightly edematous and erythematous
bilaterally, but the nasal passages were clear.
Chest auscultation revealed faint expiratory
wheezes at both lung bases. The heart and
abdomen were normal. Extremities showed
no dubbing or edema. Peak expiratory flow
rate was 520 /im (95% of predicted).
Allergy testing by the epicutaneous
(skin prick) technique showed a positive
reaction to cockroach extract, with a wheal
diameter of 6 mm and a flare diameter of
30 mm. Other positive skin tests included
mixed ragweed, maple tree pollen, cat, dog,
and dust mite (Derf ) extracts. There was a
borderline reaction to Aspergillusfiumigatus.
The patient was instructed to increase his
flunisolide MDI to six puffs twice daily. He
was educated about the need for and meth-
ods of reducing his exposure to cockroach
and dust mite allergens. He was given
smoking cessation counseling. He was edu-
cated on how to prevent gastroesophageal
reflux and treated with oral omeprazole.
A visit was made to the patient's home
as part of a pilot research project. He and
his wife lived on the top floor of a four-
story wood-frame building in a low-income
neighborhood in Boston, Massachusetts.
On inspection, their small one-bedroom
apartment had severe cockroach infestation.
Living cockroaches were seen in numerous
locations in the kitchen and entryway of the
apartment. Dead cockroaches were seen in
all cabinets, and roach stains were noted in
numerous locations. The bedroom had low-
pile carpeting, and the patient's mattress
and pillows did not have allergen-imperme-
able covers. Dust specimens were collected
according to a standard research protocol
and sieved to separate the fine dust, which
was extracted and assayed for the cockroach
allergen Bla g 1 by a monoclonal antibody
enzyme-linked immunosorbent assay
(ELISA). The concentration of Bla g 1 in
the bed, bedroom floor, and kitchen floor
were 0.77, 3.3, and 29 U/g of dust, respec-
tively. In dust vacuumed from the bed, the
concentration of the dust mite allergens Der
f 1 and Der p 1 were low (0.073 pg/g of
dust) and undetectable, respectively. Dust
from the bedroom floor had a moderate
concentration of Derfl (1.3 pg/g of dust).
Intensive cleaning and professional pest
control were carried out in the patient's
apartment as part of the pilot research pro-
ject. The patient was educated in the meth-
ods of integrated pest management.
Chemical controls included gel baits, bait
stations, and boric acid powder inside wall
voids. The patient's mattress and pillows
were encased in allergy-proof covers.
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One month later he returned to the
clinic. He reported a large reduction in
cockroaches in his home after the interven-
tion. He had stopped smoking and was
using the inhaled corticosteroid as pre-
scribed. He was taking omeprazole daily
and reported that his symptoms of gastroe-
sophageal reflux had resolved. He reported
that his symptoms of wheezing, dyspnea,
cough, and chest tightness were much less
frequent, although he was still requiring
albuterol about 3 days/week.
Discussion
The evaluation of the patient with asthma
should always indude a search for environ-
mental factors that may cause or aggravate
this condition. These factors include
inhaled or ingested allergens, inhaled irri-
tants, and medications such as aspirin or
beta blockers, which aggravate symptoms
in some asthmatics by pharmacologic
mechanisms. Inhalational exposure to aller-
gens and irritants may occur in the home,
in the workplace, out of doors, or in any
combination of these. Examples of poten-
tially harmful exposures in the home
include cat and dust mite allergens (1),
environmental tobacco smoke (2), and
household cleaners that release irritating
fumes. Workplace exposures that may
cause or aggravate asthma are numerous
(3): some common examples include flour
dust in bakeries, isocyanates and other
components of spray paint in auto body
shops, and quarternary ammonium com-
pounds in the antiseptic cleaners used by
hospital housekeeping workers. Outdoor
exposures that may aggravate asthma
include Alternaria spores and the ambient
pollutants ozone (4) and fine particles (5).
Cockroach Allergy and Asthma
Immunoglobulin E-mediated (type 1)
hypersensitivity plays a central role in the
pathogenesis of many cases of asthma. In
genetically susceptible persons, exposure to
allergenic substances derived from animals
and plants is often a critical environmental
factor influencing the development and
severity of this condition, and a growing
body of evidence has implicated allergens
derived from cockroaches as being particu-
lary important in this regard.
Following early reports (6,7) that some
allergy patients displayed immediate cuta-
neous hypersensitivity to cockroach extract,
Bernton and Brown (8,9) systematically
evaluated cockroach sensitivity among aller-
gy dinic patients. In Washington, DC, they
observed that 28% of 114 unselected allergy
patients had positive allergy skin tests to
German cockroach (Blattella germanica)
extract, compared with only 7.5% of 253
healthy control subjects (8). In New York
City, 44% of 589 patients seen at hospital-
based allergy clinics had positive skin test
reactions to German cockroach extract (9).
Analysis by ethnic subgroup revealed strik-
ing variation in the prevalence of skin test
reactivity to cockroach extract, with a preva-
lence of 59% among Puerto Rican patients.
The authors conduded that the high preva-
lence of skin test reactivity among Puerto
Rican patients in New York was related to
the high prevalence of cockroach infestation
in the homes of this group, consistent with
the observation that atopic persons tend to
develop sensitization to the allergens most
common in their environment.
Subsequent reports have revealed mod-
erate to high rates of immediate cutaneous
hypersensitivity to cockroach extract among
asthma and allergy patients in other U.S.
cities (10-14) and in other parts of the
world (15-17). For example, data from the
National Cooperative Inner-City Asthma
Study (NCICAS) indicated that 36% of
1,286 asthmatic children living in low-
income communities in six northeastern
U.S. cities had a positive allergy skin test to
German cockroach extract (13). In a study
of asthmatic children in metropolitan
Baltimore, Maryland, urban children were
more likely to have a positive skin test to
cockroach extract than were suburban chil-
dren, and African-American race and low
socioeconomic status were independently
associated with skin test reactivity to cock-
roach extract (18).
The potential relevance of cockroach
hypersensitivity to asthma has been sup-
ported by specific bronchial provocation
studies. Most asthma patients with positive
skin tests to cockroach extract develop an
acute asthmatic response upon inhalation of
cockroach extract aerosol in the laboratory
(19,20). Most of these
patients also display a-
late asthmatic reaction ^
(dual response) hours
later (20). Cockroach
skin test-negative asth-
matics, in contrast, do
not react upon inhal- -
ing aerosols of cock-
roach extract (19,20). i
The immunologic
and molecular charac-
terization of major
cockroach allergens has -
greatly facilitated the
clinical and epidemio-
logic investigation of
cockroach allergy and
asha Muc of ths* uFgure 1. German cockasthma. h of th's Reproduced from Urb,
work has focused on Agricultural Sciences, 1
allergens derived from mission from the Univer
the German cockroach (see Fig. 1), the most
common cockroach species infesting homes
in cities in the United States and many other
parts of the world. Multiple allergens have
been observed in extracts of German cock-
roach, some specific to the German cock-
roach and some cross-reactive with allergens
from other species such as the American
cockroach (Penplaneta americana; see Fig. 2)
(21-26). Two major German cockroach
allergens, so defined on the basis of the high
prevalence of specific IgE against them
among cockroach-allergic patients, have been
designated B/ g 1 and Bag 2 (24,25). Bag
1 is a 25- to 35-kd protein that has been
purified from both German and American
cockroaches (24). Approximately 30% of
cockroach-allergic patients in Virginia were
found to have IgE specific for this allergen
(25). Blag2 is a 36-kd protein specific to the
German cockroach (25); approximately 60%
of cockroach allergic patients in Virginia had
IgE specific to this allergen. Molecular
cloning of the B/a g 2 allergen has revealed
sequence homology to aspartic proteases, and
a high concentration of Bla g 2 has been
observed in the cockroach digestive system,
suggesting that the allergen may be a diges-
tive enzyme (27). Another recently character-
ized German cockroach allergen, Bla g 4, is a
21-kd protein for which 40-60% of cock-
roach-allergic patients in Virginia had specif-
ic IgE (28). Sequence homology suggests
that this protein may be a calycin (28).
ELISAs for major cockroach allergens,
particularly B/ g 1 (29,30) and B/ag2 (29),
provide a method for measuring the levels of
these allergens in the home and other envi-
ronments. Both monoclonal (29) and
monospecific polyclonal (30) antibodies
have been employed in these assays. Usually
applied to vacuumed dust samples, these
measurements provide estimates of exposure
kroach (Blattella germanica) male (A) and female (B).
Pan Entomology [W Ebeling. Berkeley, CA:Division of
University of California Berkeley, 1978;Plate ill) with per-
rsity of California Board of Regents.
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that are presumably more accurate and more
relevant to biologic effects than are exposure
estimates based on observations of the num-
ber of cockroaches seen or trapped in a par-
ticular environment. A high proportion of
low-income urban homes have detectable
cockroach allergen in vacuumed house dust
(18,29,31). For example, 27 (71%) of 38 of
urban homes sampled in Atlanta, Georgia,
had detectable Bla g 1 in vacuumed dust
(range 4-1,340 U/g of fine dust) (29). In
NCICAS, the homes of 406 (85%) of 476
urban asthmatic children had detectable Bla
g 1 allergen in bedroom dust, and 239
(50%) of the homes had levels exceeding 8
U/g of dust (31). In the northeastern United
States, high levels of Bla g 1 or Bla g 2 in
vacuumed dust are associated with urban
residence, African-American race, and low
socioeconomic status (18,32). Within a
given home, the highest cockroach allergen
levels are usually in the kitchen, where food
and moisture promote infestation, although
substantial levels of allergen are also measur-
able in bedding, bedroom floors, and uphol-
stered furniture (29,32). In a study in
Wilmington, Delaware, 20% of homes with
no visible evidence of cockroach infestation
had detectable levels of Bla g 2 in at least
one room (29). Cockroach allergens appear
to be associated with relatively large particles
that remain airborne in detectable quantities
for only a short time after disturbance (33).
Studies employing ELISA measurements
of cockroach allergens have suggested that
exposure to these allergens in the home may
promote allergic sensitization to cockroach-
es. Among 81 asthmatic children in
Baltimore, the levels of cockroach allergen
(Bla g 1 or Bla g 2) in the bedroom were sig-
nificantly associated with skin test reactivity
to cockroach extract, even after adjustment
for covariates including age, race, and socio-
Figure 2. American cockroach (Periplaneta americana)
Reproduced from Urban Entomology [W Ebeling.
Agricultural Sciences, University of California Berkele,
mission from the University of California Board of RegE
economic status (18). Of the 22 asthmatic
children with a bedroom level of Bla g 1 or
Bla g 2 exceeding 1 U/g of dust, over 80%
had a positive skin test to cockroach extract.
Cross-sectional studies of current hypersen-
sitivity and exposure status are unable to
elucidate the temporal and dose-response
aspects of the relation of exposure to the
development of allergic sensitization. The
hypothesis that exposure to cockroach aller-
gen is an independent risk factor for the ini-
tial development of asthma is untested,
although it is currently being evaluated by
longitudinal birth-cohort studies.
Several studies have addressed the
hypothesis that exposure to cockroach aller-
gen may be an independent risk factor for
exacerbation of existing asthma. Case-con-
trol studies of children in Atlanta (34) and
adults in Wilmington (32) revealed that sub-
jects presenting with acute asthma exacerba-
tions were substantially more likely than
nonasthmatic controls to have the combina-
tion of sensitivity to an indoor allergen
(cockroach, dust mite, or cat) and significant
exposure to that allergen in their home. Most
of this association, however, was explained
by the association between asthma and aller-
gic sensitization per se, and these studies do
not establish with certainty whether the level
of exposure to cockroach and other indoor
allergens is related to the risk of asthma exac-
erbation among sensitized asthmatics.
The NCICAS examined skin test sensitiv-
ity, bedroom dust allergen levels, and asthma
morbidity among 476 asthmatic children
(31). Children with the combination of a pos-
itive skin test reaction to cockroach extract
and a bedroom level of B/a g 1 exceeding 8
U/g of dust had significantly more hospitaliza-
tions for asthma, unscheduled medical visits,
and parent-reported wheezing than other chil-
dren. Neither cockroach skin test reactivity in
the absence of expo-
sure nor cockroach
allergen exposure in
the absence of skin test
reactivity was associat-
ed with increased
i morbidity. In this
population, exposure
to dust mite and cat
allergens was much
less common than
exposure to cockroach
allergen, and neither
cat nor dust mite aller-
gen exposure was sig-
nificantly related to
asthma morbidity.
male (A) and female (B) It has been suggested
Berkeley, CA:Division of that cockroach aller-
y, 1978;Plate ll] with per- gy is associated with
ents. particularly severe
and chronic asthma (35,36). While it is
indeed possible that cockroach allergen is
more likely than other allergens to induce
severe and chronic asthma symptoms, the
severity and persistence of asthma in cock-
roach-sensitized residents of the inner city
may relate to the effects of cockroach aller-
gen exposure combined with other factors
associated with poverty, including limited
access to medical care and medications, low
birth weight, prematurity, obesity, dietary
factors, and smoking.
Evaluation and Management of the
Patient
The clinical presentation of cockroach-aller-
gic asthma is typically nonspecific.
Occupational asthma in a laboratory worker
who reported symptoms whenever working
with a certain species of cockroaches has
been reported (19), but such cases are
unusual. More typically, exposure is related
to infestation of the home or workplace, and
is not recognized by the patient to be an
environmental factor relevant to asthma.
Because the exposure is chronic and the
source of the allergen may not be apparent
to the patient, there is often no clear history
of asthma symptoms having been precipitat-
ed by exposure. Instead, there is usually a
nonspecific history of perennial asthma, pos-
sibly worse in the winter, when more time is
spent indoors (36). Patients may report
aggravation of asthma symptoms by house-
hold cleaning activities, particularly in areas
with visible evidence of cockroach infesta-
tion, and rare patients may even have experi-
enced a rash at sites where cockroach bodies
contacted their skin during cleaning.
Occasionally, as in the case reported here, a
patient may voice suspicion of cockroach
allergy, but more often cockroach allergy
becomes a consideration because of a physi-
cian inquiry about cockroach infestation or
because of a positive allergy skin test result.
Because cockroaches spend most of their
time hidden from sight in small harborages,
infestation and significant allergen exposure
may be present in a home in which cock-
roaches are rarely seen by the occupants.
Patients with poorly controlled asthma
and possible cockroach exposure should
undergo allergy skin testing with either
German cockroach extract or mixed
German and American cockroach extract.
Commercially available cockroach extracts
have been reported to vary considerably in
the concentration of major cockroach aller-
gens (25), but the impact of this variability
on test sensitivity has not been defined.
When allergy skin testing is not possible,
serum IgE specific for cockroach allergens
can be measured by the radioallergosorbent
test (RAST). A positive skin test or serum
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RAST in the context of poorly controlled
asthma and reported cockroach infestation
should be taken as evidence of cockroach-
allergic asthma. In some cases, cockroach
may be the only identifiable allergen (7,12),
but more often, patients are sensitized to
multiple indoor and/or outdoor aeroallergens
(12), as in the case of the patient described.
In addition to therapy with antiinflam-
matory and bronchodilator medications,
the management of cockroach-allergic asth-
ma should include efforts to reduce expo-
sure to cockroach allergens in the home or
work environment. Avoidance of dusty jobs
in cockroach-infested buildings and the use
of respiratory protection when undertaking
such jobs are logical steps to recommend.
Exposure in the home will be optimally
reduced by moving out of the infested
home and into a noninfested one, but this
is rarely feasible. For more patients, avoid-
ance measures will consist of efforts to
reduce cockroach infestation and cockroach
allergen levels in the home. Cockroach
infestation in the home can usually be
greatly reduced or even eliminated by com-
bining the approach of integrated pest man-
agement (IPM) with the use of modern
chemical controls. IPM is a strategy for
making the environment as inhospitable as
possible for cockroaches by sealing entry
points and small enclosed spaces (harbor-
ages) and eliminating sources of water (e.g.,
leaking pipes) and food (e.g., sealing all
open food in plastic or glass and rigorously
cleaning crumbs from the floor). Chemical
controls favored by most pest-control
authorities include hydramethylnon or
abamectin gel baits and bait stations, some-
times combined with the application of
boric acid powder in harborages before they
are sealed or in other areas not accessible to
gel baiting. Hydroprene, an insect growth
retardant, is also favored by some authori-
ties as an additional component of an
aggressive cockroach control program. In
cases of a heavy infestation, cockroaches
may be flushed out of harborages with hot
air and then removed by a vacuum cleaner
to achieve a quick reduction in their popu-
lation. Insecticide sprays are not recom-
mended, both because they are less effica-
cious than gel baits and because inhalation
of these products may provoke asthma
symptoms (37).
Unfortunately, cockroach allergens are
persistent in the indoor environment and
are still measurable in vacuumed dust even
after the cockroach population has been
greatly reduced. One study of an urban dor-
mitory chronically infested with German
cockroaches showed that the professional
application of pesticide followed by vacu-
uming was associated with significant
reductions in the concentration of the Bla g
2 in dust vacuumed from kitchen and bed-
room floors as well as from bedding (38).
Preliminary data from recent studies in
urban homes, however, have revealed disap-
pointingly little rapid impact of professional
pest control and cleaning on dust concen-
trations of cockroach allergens (39). It is
possible that pest control combined with
rigorous cleaning may reduce the total
amount of allergen in a home, although the
concentration of allergen in vacuumed dust
may decline more slowly. Research efforts
are under way to determine the optimal
methods of reducing cockroach allergen in
infested homes as well as the optimal metric
for quantifying exposure.
Immunotherapy with cockroach extract
has been reported to lead to a beneficial
change in immunological and clinical para-
meters in one small study (40), but the role of
immunotherapy in asthma remains contro-
versial, and immunotherapy for cockroach-
allergic asthma is not generally considered a
modality of proven efficacy at this time.
An aspect of this case that is typical of
patients with cockroach allergy and asthnma is
that the cockroach allergy was not the only
factor influencing the severity of asthma
symptoms. Skin testing revealed hypersensi-
tivity to multiple indoor and outdoor aller-
gens, and dust mite avoidance measures were
recommended along with cockroach remedi-
ation. Although bed levels of dust mite aller-
gen were low, encasement of the mattress
and pillows may have reduced exposure to
dust mite as well as cockroach allergens. The
patient was smoking cigarettes upon initial
presentation, and he subsequently succeeded
in quitting, which may have contributed to
his clinical improvement. In addition, he ini-
tially reported symptoms of gastroesophageal
reflux, a common condition that can aggra-
vate asthma. Education and medical treat-
ment led to improvement of his reflux symp-
toms, which in turn may have contributed to
the improvement of his asthma. Finally, he
was treated with a higher dose of inhaled
corticosteroid. Asthma is a complex, multi-
factorial condition, and the management of
patients with poorly controlled asthma often
involves multiple modalities of environmen-
tal and medical intervention.
Conclusion
A growing body of evidence indicates that
cockroach allergy is a major environmental
risk factor for the aggravation of asthma. The
symptoms of patients with cockroach-allergic
asthma, as in this case, are nonspecific, and
questioning by the clinician about infestation
accompanied by allergy skin testing or serum
RAST are crucial to making the diagnosis. In
addition tO asthma medications, management
should include efforts to reduce exposure to
cockroach allergens. The combination of
cockroach control measures, including IPM
techniques and chemical controls, and thor-
ough cleaning is a logical step to reduce expo-
sure to cockroach allergen, but the clinical
efficacy of such an intervention has yet to be
demonstrated. Although modern cockroach-
control approaches can greatly reduce the
level of infestation in a home, it appears to be
difficult to achieve rapid reductions in cock-
roach allergen levels. Immunotherapy with
cockroach extract is of uncertain clinical ben-
efit at this time. Although the proportion of
asthma morbidity in the inner city attribut-
able to cockroach allergy is not known, it
may be substantial. Cockroaches do not
respect the borders between apartments, and
reducing asthma morbidity related to cock-
roach allergy may require a focus that extends
beyond the individual patient to neighbor-
hood and community efforts to improve
housing conditions.
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Excellence in basic research at the
National Institute of Environmental Health Sciences
NIEHS scientists and grantees are performing basic studies of our susceptibility to environment-related disease:
demonstrating that a carcinogen in cigarette smoke (benzo(a)pyrene) alters part of a gene to cause lung cancer . . .
showing the effects of fetal exposure to PCBs ... developing a strain of mouse that lacks functional estrogen receptors
and that helps evaluate how some pesticides and other estrogen-like compounds might affect development and
reproduction . discovering the genes for breast, ovarian, and prostate cancers ... identifyingw Qtia days
of fertility... seeking to reverse the damage from lead exposure ... finding alternatives
pipointing the functions of specific genes by eliminating them from specially bred mouse.1
jjlnary yeast cells, to isolate and clone genes and other fragments of genetic material
ubn air on lung function..
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